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UPREGULATION OF A NOVEL PROTEIN IN HCC ENHANCES CANCER CELL 
SURVIVAL BY SUPPRESSING SPECIFIC APOPTOTIC EFFECTORS. 
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Background and Aims: Altered cell survival is a hallmark of cancer, including 
primary HCC. The aim of our study is to identify novel anti-apoptotic genes promoting 
liver tumourigenesis. 
 
Methods: We used a combination of in vitro and in vivo analyses to identify novel 
anti-apoptotic genes. We compared the ability of HCC cells stable-expressing either 
shRNA against HD (a newly-identified anti-apoptotic molecule) or control shRNA to 
growth in vivo and in vitro. 
 
Results: By examining the expression pattern of HD  mRNA in a panel of human 
neoplasms and cancer cells, we demonstrated that HD is highly expressed in both 
HCC cells and liver biopsies. mRNA profiling showed significantly higher expression 
of HD transcripts in HCC samples compared to normal livers (**P=0.0062) and 
adjacent non-tumor tissues (***P<0.0001). Elevated HD expression also correlates 
with HCC progression and poor prognosis. Protein analyses confirmed that HD levels 
were significantly increased in HCC tissues and hepatoma lines compared to healthy 
livers. Notably, xenograft experiments demonstrated that suppression of HD strongly 
impaired tumor formation in vivo. Knockdown of HD significantly reduced proliferation 
and markedly increased apoptosis of hepatoma cells.  
 
Conclusion: We report that HD mRNA and protein are frequently overexpressed in 
HCC tissue compared with non-tumour liver tissues, where it correlates with poor 
patient survival. Enforced expression of HD was sufficient to enhance cell survival, 
whereas silencing of HD was greatly enhances apoptosis. Notably, HD attenuation in 
HCC cells also suppressed activation of specific apoptotic markers, thus suggesting 
that HD is an important novel anti-apoptotic marker for liver tumourigenesis. 
 
